MedTrace Logo

A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives

NCT00301587 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-09-20

No results posted yet for this study

Summary

The purpose of this study is to compare red blood cell folate levels in women who are taking oral contraceptives with or without folic acid

Conditions

  • Neural Tube Defects
  • Congenital, Hereditary, and Neonatal Diseases and Abnormalities
  • Nervous System Malformations

Interventions

DRUG

Norgestimate-ethinyl estradiol, with or without folic acid

Sponsors & Collaborators

  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Completion
2004-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00301587 on ClinicalTrials.gov